Alan Snyder is a Dermatology physician affiliated with Medical University of South Carolina. OpenAlex indexes 45 publications with 438 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
171 Ashley Ave
Charleston, SC 294258905
Telephone
910-619-5832Provider last certified this registry record 6 Apr 2025.
Industry payments
27 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20255 payments
- Novartis Pharmaceuticals CorporationProgram year20254 payments
- Blueprint Medicines CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
36.7%Corticosteroid15.3%Triamcinolone Acetonide100%Part D≥21 patientsInterleukin-4 Receptor alpha Antagonist14.7%Dupixent Pen100%Part D<11 patients+ 1 more class in this area
Anti-infectives
23.2%Azole Antifungal16.9%Ketoconazole100%Part D≥12 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor6.2%Valacyclovir100%Part D<11 patientsSensory organs
22%Corticosteroid22%Clobetasol Propionate62%Hydrocortisone39%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- JAK of All Trades: A Case Series of Oral Janus Kinase Inhibitors for Treatment of Lichen Planus
SKIN The Journal of Cutaneous Medicine
2025 - 63195 Adverse Event Profile of Cyclosporine in Dermatological Diseases
Journal of the American Academy of Dermatology
2025 - Basic Science and Principles of Stem Cells, Platelet‐Rich Plasma, and Exosomes
Dermatological Reviews
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Tanya Turan, MD
Medical University of South Carolina
Michael Zile, MD
Medical University of South Carolina
Don Rockey, MD
Medical University of South Carolina
Katherine Ruzhansky, MD
Medical University of South Carolina
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”